Navigation Links
GCpro Taq DNA Polymerase Complete System from GenScript Corporation

ProductsGCpro Taq DNA Polymerase Complete System from GenScript Corporation
Company GenScript Corporation
Item GCpro Taq DNA Polymerase Complete System
Price $125.00
Description GCpro Taq DNA Polymerase is a versatile and easy-to use enzyme, with powerful advantages for all PCR applications. GCpro Taq DNA Polymerase is prepared from a recombinant clone expressed in E. coli, containing the DNA polymerase I gene from Thermococcus litoralis. The enzyme includes a highly processive 5'-3' DNA polymerase activity. Its inherent 3'-5' proofreading activity results in a greatly increased fidelity of DNA synthesis compared to Taq DNA Polymerase. The enzyme includes an optimized reaction buffer, which enables the amplification of GC-rich templates and problematic templates with secondary structures that interfere with the PCR process. GCpro Taq DNA Polymerase provides a very robust synthesis of longer GC-rich amplification products. GCpro Taq DNA Polymerase has all the properties of regular Taq DNA Polymerases for every standard PCR application. It is versatile, user-friendly and compatible with all PCR applications such as GC-rich and other complex templates, site-directed mutagenesis as well as TA cloning due to its extendase activity.
Info GenScript CorporationGenScript Corporation
120 Centennial Ave.
Piscataway, NJ 08854
USA

Customer Service: (Toll Free) : (877) 436-7274
(732) 885-9188
(732) 885-9688
Fax Number: (732) 210-0262
(732) 885-587
Web Site: http://www.genscript.com/
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. T4 DNA Polymerase from Roche Applied Science
2. T4 DNA Polymerase from Roche Applied Science
3. Poly A Polymerase from Invitrogen
4. iTaq DNA Polymerase, 250 U from Bio-Rad
5. iTaq DNA Polymerase, 5,000 U from Bio-Rad
6. Taq DNA Polymerase, 500 U (2 x 250 U) without dNTP from Bioneer, Inc.
7. T4 DNA Polymerase from Invitrogen
8. T4 DNA Polymerase from New England Biolabs
9. SP6 RNA Polymerase from Roche Applied Science
10. Taq DNA Polymerase (cloned) from GE Healthcare, formerly Amersham Biosciences
11. Mango-Taq DNA Polymerase from Bioline
... Large T antigen initiates replication ... replication in the presence of ... product can be used in ... Replication Kit cat. no. 8050. ...
NuParaffin Kit Application: Flow Cytometry Reactivity: Human...
Request Info...
...
Biology Products:
(Date:5/25/2015)... 2015  Australia,s market for wearable technologies is considered ... the advent of several trials and prototypes. The release ... expected to ignite interest in wearables as well as ... . This in turn will spur greater innovation ... partnerships amongst vendors and distributors. Photo ...
(Date:5/22/2015)... According to a new market research report ... by Software (Middleware, Databases), by Hardware (Cameras, Integrated Devices), ... - Global Forecast to 2020", published by MarketsandMarkets, Facial ... to $6.19 Billion by 2020, at a CAGR of ... and   43 Figures spread through 140 Pages and ...
(Date:5/21/2015)... The Sync Project™ , a global collaboration harnessing ... a collaborative partnership with Berklee,s Institute for Creative ... on original research, joint course development and an internship ... Sync Project and BerkleeICE are exploring the launch of ... academic year.  The course will focus ...
Breaking Biology News(10 mins):Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3
... , , , , , ... AUDIO: Plants capable of producing oils for industrial chemicals and human health are ... Click here for more information. , , , ... , , , , , ...
... de-acetylase (HDAC) inhibitor panobinostat is able to target and ... published in BioMed Central,s open access journal Breast ... Center have shown that panobinostat was able to destroy ... Approximately 15% of breast cancers are found at ...
... Barcelona, 20 May 2012. The Stem Cells and Cancer ... the Vall d,Hebrn Institute of Oncology (VHIO) has identified ... drugs used in clinical trials for colon cancer treatment. ... collaboration with Professor Alberto Muozs laboratory at the Instituto ...
Cached Biology News:Supercharged safflower 2Supercharged safflower 3Supercharged safflower 4Blocking DNA: HDAC inhibitor targets triple negative breast cancer 2Discovery of mechanisms predicting response to new treatments in colon cancer 2Discovery of mechanisms predicting response to new treatments in colon cancer 3
(Date:5/26/2015)... NORTH CHICAGO, Ill. , May 26, 2015 ... biopharmaceutical company, announced today that it has completed ... and commercial presence in oncology. Pharmacyclics is a ... (ibrutinib), a first-in-class BTK-inhibitor used to treat hematological ... "The companies, shared expertise, combined with AbbVie,s broad ...
(Date:5/25/2015)... a science-driven healthcare company seeking to solve some of ... that Dame Marjorie Scardino , Chairman of the ... appointed to PureTech,s Board of Directors in the role ... Joi Ito , MIT Media Lab,s Director, has ... PureTech,s outgoing Chairman and co-founder, former Executive Vice President ...
(Date:5/22/2015)... DUBLIN , May 22, 2015  Actavis plc ... of the U.S. Court of Appeals for the Second ... 2014 preliminary injunction requiring the Company to continue distribution ... Logo - http://photos.prnewswire.com/prnh/20130124/NY47381LOGO   ... uphold this ruling, we intend to continue our strong ...
(Date:5/22/2015)... -- Baylor Research Institute (BRI) at ... (TGen) in Phoenix, AZ , today ... and treatments for patients with a broad range of cancers. ... new clinical trials and access to technology to drive the ... to bedside across Baylor Scott & White Health,s ...
Breaking Biology Technology:AbbVie Completes Acquisition of Pharmacyclics 2AbbVie Completes Acquisition of Pharmacyclics 3AbbVie Completes Acquisition of Pharmacyclics 4AbbVie Completes Acquisition of Pharmacyclics 5AbbVie Completes Acquisition of Pharmacyclics 6PureTech Adds Dame Marjorie Scardino to Board of Directors, Names Joi Ito as Chairman of the Board and Expands Management Team 2PureTech Adds Dame Marjorie Scardino to Board of Directors, Names Joi Ito as Chairman of the Board and Expands Management Team 3Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 2Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 3Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 4Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 5Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 6Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 7Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 8Precision Medicine Collaboration to Increase Options for Cancer Patients 2Precision Medicine Collaboration to Increase Options for Cancer Patients 3Precision Medicine Collaboration to Increase Options for Cancer Patients 4